Role of systemic and epicardial adipose tissue in cardiometabolic disease - PubMed
5 hours ago
- #epicardial adipose tissue
- #cardiometabolic disease
- #adipose tissue
- Adipose tissue is recognized as an immunological and metabolic organ with diverse effects on cardiometabolic health.
- Distribution and phenotypic state of adipose depots (visceral, subcutaneous, epicardial) influence cardiovascular risk.
- Adipose tissue communicates with vasculature and myocardium via endocrine, paracrine, vasocrine, and neural pathways.
- Advances in imaging technologies enable highly reproducible measurements of adipose tissue volume, quality, density, and radiomics.
- Multiomics data link specific adipose tissue patterns to inflammation and cardiovascular disease pathways.
- The 'unified adipose tissue' model emphasizes adipose tissue biology over total mass in driving cardiometabolic disease.
- There are emerging insights into depot-specific biology, imaging phenotyping, ethnicity- and sex-related differences, and therapeutic modulation.